<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Law ZK</submitter><funding>British Heart Foundation</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><pagination>1141-1148</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7612544</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>53(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage-2) randomized controlled trial.&lt;h4>Methods&lt;/h4>Consent was provided by patients or by a relative or an independent doctor in incapacitated patients, using a 1-stage (full written consent) or 2-stage (initial brief consent followed by full written consent post-randomization) approach. The computed tomography-to-randomization time according to consent pathways was compared using the Kruskal-Wallis test. Multivariable logistic regression was performed to identify variables associated with onset-to-randomization time of ≤3 hours.&lt;h4>Results&lt;/h4>Of </pubmed_abstract><journal>Stroke</journal><pubmed_title>Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial.</pubmed_title><pmcid>PMC7612544</pmcid><funding_grant_id>SP/12/2/29422</funding_grant_id><funding_grant_id>G108/613</funding_grant_id><funding_grant_id>NF-SI-0515-10044</funding_grant_id><funding_grant_id>14/190/01</funding_grant_id><funding_grant_id>11/129/109</funding_grant_id><funding_grant_id>CS/18/2/33719</funding_grant_id><funding_grant_id>G1002605</funding_grant_id><funding_grant_id>NIHR201309</funding_grant_id><funding_grant_id>11_129_109</funding_grant_id><funding_grant_id>NIHR128694</funding_grant_id><pubmed_authors>Lyrer PA</pubmed_authors><pubmed_authors>Scutt P</pubmed_authors><pubmed_authors>Beridze M</pubmed_authors><pubmed_authors>Duley L</pubmed_authors><pubmed_authors>Laska AC</pubmed_authors><pubmed_authors>Appleton JP</pubmed_authors><pubmed_authors>Werring DJ</pubmed_authors><pubmed_authors>Bath PM</pubmed_authors><pubmed_authors>Shone A</pubmed_authors><pubmed_authors>TICH-2 Investigators</pubmed_authors><pubmed_authors>England TJ</pubmed_authors><pubmed_authors>Collins R</pubmed_authors><pubmed_authors>Bereczki D</pubmed_authors><pubmed_authors>Thanabalan J</pubmed_authors><pubmed_authors>Robinson T</pubmed_authors><pubmed_authors>Ciccone A</pubmed_authors><pubmed_authors>Law ZK</pubmed_authors><pubmed_authors>Egea-Guerrero JJ</pubmed_authors><pubmed_authors>Ozturk S</pubmed_authors><pubmed_authors>Krishnan K</pubmed_authors><pubmed_authors>Sprigg N</pubmed_authors><pubmed_authors>Dineen RA</pubmed_authors><pubmed_authors>Roberts I</pubmed_authors><pubmed_authors>Roffe C</pubmed_authors><pubmed_authors>Al-Shahi Salman R</pubmed_authors><pubmed_authors>Karlinski M</pubmed_authors><pubmed_authors>Christensen H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial.</name><description>&lt;h4>Background&lt;/h4>Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage-2) randomized controlled trial.&lt;h4>Methods&lt;/h4>Consent was provided by patients or by a relative or an independent doctor in incapacitated patients, using a 1-stage (full written consent) or 2-stage (initial brief consent followed by full written consent post-randomization) approach. The computed tomography-to-randomization time according to consent pathways was compared using the Kruskal-Wallis test. Multivariable logistic regression was performed to identify variables associated with onset-to-randomization time of ≤3 hours.&lt;h4>Results&lt;/h4>Of </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-05-09T19:51:36.846Z</modification><creation>2025-04-05T09:57:57.24Z</creation></dates><accession>S-EPMC7612544</accession><cross_references><pubmed>34847710</pubmed><doi>10.1161/STROKEAHA.121.035191</doi></cross_references></HashMap>